Skip to main content

Advertisement

Log in

Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management

  • Special Feature
  • RFA of primary breast cancer
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

There is increasing demand for minimally invasive treatments for small breast cancer mainly because of the desire for better cosmetic results. Although radiofrequency ablation (RFA) is an attractive approach as a local control method for small breast cancer, the problems of histological effectiveness and safety management remain.

Methods

A total of 29 patients including one patient with bilateral breast cancer were enrolled in this study. The mean tumor size of 30 breasts was 12.8 mm (range 5–19 mm). Under general anesthesia, RFA was performed with a Cool-tip RF system (Valleylab, Boulder, CO, USA) after sentinel lymph node biopsy. Postoperative evaluation with magnetic resonance imaging (MRI) and vacuum-assisted core needle biopsy was done 3–4 weeks after RFA before radiotherapy. Ablated tumors were evaluated with hematoxylin–eosin (H&E) and nicotinamide adenine dinucleotide (NADH)-diaphorase staining. If needed, adjuvant chemo and/or endocrine therapy was performed.

Results

All patients except one completed one session of RFA. The mean temperature near the center of the tumors was 89.6°C (range 78–100°C). Postoperative MRI showed the ablated zone clearly in all patients. MRI revealed no hypervascularity of the tumors in the ablated zone. Evaluation with H&E staining of the tumors showed remarkable degenerative changes in only three patients. NADH-diaphorase staining showed no viable tumor tissue in 24 patients out of 26 examined. Three patients received small diameter grade 3 skin burns, two on the outside of the thigh from the grounding pad and one on the breast skin. One patient had a breast lesion like a chronic granulomatous mastitis resulting from overreaction of the ablated zone.

Conclusions

RFA therapy appeared relevant and applicable for patients with small breast cancer. Because small skin burns were observed as adverse events, close attention should be paid in the course of the RFA procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

RFA:

Radiofrequency ablation

MRI:

Magnetic resonance imaging

MDCT:

Multi-detector computed tomography

H&E:

Hematoxylin–eosin

NADH:

Nicotinamide adenine dinucleotide

References

  1. Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL, Nowels KW, Dirbas FM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg. 1999;134:1064–8.

    Article  CAS  PubMed  Google Scholar 

  2. Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, et al. Radiofrequency ablation in patients with primary breast carcinoma. A pilot study in 26 patients. Cancer. 2001;92:2036–44.

    Article  CAS  PubMed  Google Scholar 

  3. Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, et al. Radiofrequency ablation of solid tumors. Cancer J. 2001;7:95–102.

    CAS  PubMed  Google Scholar 

  4. Singletary SE. Feasibility of radiofrequency ablation for primary breast cancer. Breast Cancer. 2003;10:4–9.

    Article  PubMed  Google Scholar 

  5. Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol. 2006;93:120–8.

    Article  PubMed  Google Scholar 

  6. Imoto S, Wada N, Sakemura N, Hasebe T, Murata Y. Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients. Breast. 2009;18:130–4.

    Article  PubMed  Google Scholar 

  7. Elliott RI, Rice PB, Suits JA, Ostrowe AJ, Head JF. Radiofrequency ablation of a stereotactically localized nonpalpable breast carcinoma. Am Surg. 2002;68:1–5.

    PubMed  Google Scholar 

  8. Burak WE Jr, Agnese DM, Povoski SP, Yanssens TL, Bloom KJ, Wakely PE, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer. 2003;98:1369–76.

    Article  PubMed  Google Scholar 

  9. Hayashi AH, Silver SF, van der Westhuizen NG, Donald JC, Parker C, Fraser S, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg. 2003;185:429–35.

    Article  PubMed  Google Scholar 

  10. Susini T, Nori J, Olivieri S, Livi L, Bianchi S, Mangialavori G, et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma, a pilot study in elderly inoperable patients. Gynecol Oncol. 2007;104(2):304–10.

    Article  PubMed  Google Scholar 

  11. Marcy PY, Magné N, Castadot P, Bailet C, Namer M. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol. 2007;80:267–73.

    Article  PubMed  Google Scholar 

  12. Noguchi M. Radiofrequency ablation treatment for breast cancer to meet the next challenge: how to treat primary breast tumor without surgery. Breast Cancer. 2003;10:203–5.

    Google Scholar 

  13. Earashi M, Noguchi M, Motoyoshi A, Fujii H. Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer. 2007;14:39–47.

    Article  PubMed  Google Scholar 

  14. Oura S, Tamaki T, Hirai I, Yoshimasu T, Ohta F, Nakamura R, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer. 2007;14:48–54.

    Article  PubMed  Google Scholar 

  15. Nagashima T, Sakakibara M, Sangai T, Kazama T, Fujimoto H, Miyazaki M. Surrounding rim formation and reduction in size after radiofrequency ablation for primary breast cancer. Jpn J Radial. 2009;27:197–204.

    Article  Google Scholar 

  16. Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, et al. Small breast cancer treated with US-guided radiofrequency ablation. Radiology. 2004;231:215–24.

    Article  PubMed  Google Scholar 

  17. Manenti G, Bolacchi F, Perretta T, Cossu E, Pistolese CA, Buonomo OC, et al. Small breast cancers: in vivo percutaneous US-guided radiofrequency ablation with dedicated cool-tip radiofrequency system. Radiology. 2009;251:339–46.

    Article  PubMed  Google Scholar 

  18. Diesing D, Axt-Fliedner R, Hornung D, Weiss JM, Diedrich K, Friedrich M. Granulomatous mastitis. Arch Gynecol Obstet. 2004;269:233–6.

    Article  PubMed  Google Scholar 

  19. Bässler R. Mastitis. Classification, histopathology and clinical aspects. Pathologe. 1997;18:27–36.

    Article  PubMed  Google Scholar 

  20. Head JF, Elliott RL. Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients. Cancer Epidemiol. 2009;33:300–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a grant from Clinical Research for the Development of Preventive Medicine and New Therapeutics of Health and Labor Science Research from the Ministry of Health, Labor and Welfare, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naohito Yamamoto.

About this article

Cite this article

Yamamoto, N., Fujimoto, H., Nakamura, R. et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. Breast Cancer 18, 3–9 (2011). https://doi.org/10.1007/s12282-010-0197-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-010-0197-6

Keywords

Navigation